- Home
- ACIC vs BME Comparison
ACIC vs BME Comparison
Compare ACIC & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Company Overview
Basic Information| Metric | ACIC | BME |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 540.4M | 576.8M |
| IPO Year | 2007 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ACIC | BME |
|---|---|---|
| Price | $9.81 | $43.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 253.4K | 33.7K |
| Earning Date | 11-04-2026 | 01-01-0001 |
| Dividend Yield | ★ 7.63% | N/A |
| EPS Growth | ★ 39.61 | N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $335,439,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.84 | ★ N/A |
| Revenue Growth | ★ 13.07 | N/A |
| 52 Week Low | $9.01 | $37.37 |
| 52 Week High | $13.06 | $46.43 |
Technical Indicators
Market Signals| Indicator | ACIC | BME |
|---|---|---|
| Relative Strength Index (RSI) | 62.21 | 48.05 |
| Support Level | $9.79 | $43.85 |
| Resistance Level | $11.35 | $44.70 |
| Average True Range (ATR) | 0.21 | 0.65 |
| MACD | 0.09 | -0.11 |
| Stochastic Oscillator | 89.21 | 56.70 |
Price Performance
Historical Comparison ACIC
BME
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.